e-learning
resources
London 2016
Monday, 05.09.2016
Effect of sleep apnoea on life-span and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms
Silke Weber (Botucatu/SP, Brazil), Silke Weber, Flavio Pissulin, Ricardo Beneti, Francis L. Pacagnelli, Maiara Aldá, Jefferson Barros
Source:
International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Session:
Effect of sleep apnoea on life-span and comorbidities
Session type:
Thematic Poster
Number:
2355
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Silke Weber (Botucatu/SP, Brazil), Silke Weber, Flavio Pissulin, Ricardo Beneti, Francis L. Pacagnelli, Maiara Aldá, Jefferson Barros. COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms. Eur Respir J 2016; 48: Suppl. 60, 2355
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Prevalence of overlap syndrome and its correlation with severity of obstructive sleep apnea syndrome
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015
The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
Differences between patients with overlap syndrome (COPD + OSAS) and patients with OSAS
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Clinical use of the fatigue severity scale on obstructive sleep apnoea patients
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
Prevalence of positional obstructive sleep apnea and patients characteristics using various definitions
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Blood pressure indices in patients with obstructive sleep apnea and overlap syndrome
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Nocturnal desaturation in COPD patients; is OSA screening the answer?
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Prevalence and predictive factors of sleep breathing disorders (SBD) in severe COPD patients
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Clinical presentations of OSA in adults
Source: Eur Respir Mon 2010; 50: 86-103
Year: 2010
Cardiac hemodynamic in obstructive sleep apnea and overlap syndrome
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Clinical presentation and severity of obstructive sleep apnea hypopnea syndrome in Tunisian women
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Prevalence and impact of symptoms related to restless legs in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Clinical significance of transcutaneous PCO2 in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Prevalence of symptomatic gastroesophageal reflux disease (GERD) in severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016
Alternate overlap syndrome: Association of asthma with obstructive sleep apnea
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept